Literature DB >> 21701863

[Asymptomatic infections in man: a Trojan horse for the introduction and spread of mosquito-borne arboviruses in non-endemic areas?].

C Chastel1.   

Abstract

In mosquito-borne arbovirus infections in man the asymptomatic cases are much more frequent than the symptomatic ones, but their true role in the introduction and subsequent spread of such diseases in non-endemic areas remains to be clarified. We have collected pertinent data from English and French literature from 1952 to 2010 through Pubmed and other bibliographic sources. Data were analysed to assess if viremia in asymptomatic human arbovirus infections might be sufficient to represent a true risk for introduction in non-endemic areas. During dengue and chikungunya fever outbreaks, humans are believed to be the only vertebrate hosts. Since a very large number of individuals are infected and since viremic levels are known to vary by many orders of magnitude in symptomatic patients, it is reasonable to augur that a proportion of asymptomatic cases might reach levels of viremia sufficient to infect competent mosquitoes. Moreover, in both dengue and chikungunya fever, nosocomial infections have been identified representing an alternative opportunity for virus introduction in non-endemic areas. In zoonotic mosquito-borne arbovirus infections such as Japanese encephalitis or West Nile infection, the situation is quite different since humans are considered as "dead-end" hosts. However, the very large number of asymptomatic cases arising during outbreaks and the existence of newly recognised ways of contamination (blood transfusion, organ transplantation, transplacental way etc.) may also ensure their introduction and subsequent spread in new areas.

Entities:  

Mesh:

Year:  2011        PMID: 21701863     DOI: 10.1007/s13149-011-0165-1

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot        ISSN: 0037-9085


  5 in total

1.  Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate.

Authors:  Marjorie C L C Freire; Luis G M Basso; Luis F S Mendes; Nathalya C M R Mesquita; Melina Mottin; Rafaela S Fernandes; Lucca R Policastro; Andre S Godoy; Igor A Santos; Uriel E A Ruiz; Icaro P Caruso; Bruna K P Sousa; Ana C G Jardim; Fabio C L Almeida; Laura H V G Gil; Carolina H Andrade; Glaucius Oliva
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

2.  Asymptomatic humans transmit dengue virus to mosquitoes.

Authors:  Veasna Duong; Louis Lambrechts; Richard E Paul; Sowath Ly; Rath Srey Lay; Kanya C Long; Rekol Huy; Arnaud Tarantola; Thomas W Scott; Anavaj Sakuntabhai; Philippe Buchy
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-09       Impact factor: 11.205

3.  Eventual role of asymptomatic cases of dengue for the introduction and spread of dengue viruses in non-endemic regions.

Authors:  Claude Chastel
Journal:  Front Physiol       Date:  2012-03-30       Impact factor: 4.566

4.  Lactococcus lactis Strain Plasma Intake Suppresses the Incidence of Dengue Fever-like Symptoms in Healthy Malaysians: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Chee-Sieng Khor; Ryohei Tsuji; Hai-Yen Lee; Siti-Sarah Nor'e; Norhidayu Sahimin; Adzzie-Shazleen Azman; Vunjia Tiong; Pouya Hasandarvish; Boon-Teong Teoh; Yih-Harng Soh; Jian-Hai Chai; Takeshi Kokubo; Osamu Kanauchi; Naoki Yamamoto; Sazaly AbuBakar
Journal:  Nutrients       Date:  2021-12-16       Impact factor: 5.717

Review 5.  Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy.

Authors:  Simon-Djamel Thiberville; Nanikaly Moyen; Laurence Dupuis-Maguiraga; Antoine Nougairede; Ernest A Gould; Pierre Roques; Xavier de Lamballerie
Journal:  Antiviral Res       Date:  2013-06-28       Impact factor: 5.970

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.